References
- IkedaHTakahashiYYamazakiEHLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactionsEpilepsia201051229730019694795
- MarsonAGAl-KharusiAMAlwaidhMThe SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialLancet200736995661000101517382827
- McCormackMAlfirevicABourgeoisSHLA-A*3101 and carbamazepine-induced hypersensitivity reactions in EuropeansN Engl J Med2011364121134114321428769
- SuSCHungSIFanWLDaoRLChungWHSevere cutaneous adverse reactions: the pharmacogenomics from research to clinical implementationInt J Mol Sci20161711 pii:E1890
- OzekiTMushirodaTYowangAGenome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese populationHum Mol Genet20112051034104121149285
- ChenPLinJJLuCSTaiwan SJS ConsortiumCarbamazepine-induced toxic effects and HLA-B*1502 screening in TaiwanN Engl J Med2011364121126113321428768
- WuXTHuFYAnDMAssociation between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central ChinaEpilepsy Behav201019340540820833111
- NakajimaFNakamuraJYokotaTAnalysis of HLA haplotypes in Japanese, using high resolution allele typingMHC20018132 in Japanese
- ChungWHHungSIHongHSMedical genetics: a marker for Stevens-Johnson syndromeNature2004428698248615057820
- ManCBKwanPBaumLAssociation between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han ChineseEpilepsia20074851015101817509004
- MoonJParkHKChuKThe HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean populationEpilepsia20155610e161e16726282450
- JaruthamsophonKTipmaneeVSangiemchoeyASukasemCLimprasertPHLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysisSci Rep201774555328358139
- ZhouPZhangSWangYYangCHuangJStructural modeling of HLA-B*1502/peptide/carbamazepine/T-cell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysisJ Biomol Struct Dyn20163481806181726488421
- HungSIChungWHJeeSHGenetic susceptibility to carbamazepine-induced cutaneous adverse drug reactionsPharmacogenet Genomics200616429730616538176
- MiddletonDMenchacaLRoodHKomerofskyRNew allele frequency database: http:/www.allelefrequencies.netTissue Antigens200361540340712753660
- HsiaoYHHuiRCWuTGenotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlationsJ Dermatol Sci201473210110924268988
- WangQSunSXieMZhaoKLiXZhaoZAssociation between the HLA-B alleles and carbamazepine-induced SJS/TEN: a meta-analysisEpilepsy Res2017135192828618376
- ShiYWMinFLZhouDHLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactionsNeurology201788232183219128476759
- LjunggrenBBojsGA case of photosensitivity and contact allergy to systemic tricyclic drugs, with unusual featuresContact Dermatitis19912442592651831106
- SeitzCSPfeufferPRaithPBröckerEBTrautmannAAnticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agentsAnn Allergy Asthma Immunol200697569870217165282
- BabaMKarakaşMAksungurVLThe anticonvulsant hypersensitivity syndromeJ Eur Acad Dermatol Venereol200317439940112834448
- CogrelOBeylot-BarryMVergierBSodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepineBr J Dermatol200114461235123811422049
- Arévalo-LoridoJCCarretero-GómezJBureo-DacalJCMontero-LealCBureo-DacalPAntiepileptic drug hypersensitivity syndrome in a patient treated with valproateBr J Clin Pharmacol200355441541612680893
- BotaRGLigasanAPNajdowskiTGNovacAAcute hypersensitivity syndrome caused by valproic acid: a review of the literature and a case reportPerm J2011152808421841930
- MansurATPekcan YaşarSGöktayFAnticonvulsant hypersensitivity syndrome: clinical and laboratory featuresInt J Dermatol200847111184118918986457